I am a commercial leader at StemExpress helping to manage and expand our capabilities as a Clinical supplier of cellular starting material intended for further manufacture or other Clinical use. Over the past four years, I have worked with Clinical stage and pharmaceutical companies to enable and accelerate programs through initial IND filing and Phase I/II Clinical trials with GMP-compliant critical starting materials for Cell & Gene Therapy, and specifically, Allogeneic T and NK-cell-based therapeutic candidates. I am passionate and motivated to contribute to this advancing field by providing unique services and flexibility when it matters most. If you are planning to develop a cellular therapy that requires donor or patient primary or immune cells, contact me via email.